Advanced glycation end product ligands for the receptor for advanced glycation end products: Biochemical characterization and formation kinetics

Analytical Biochemistry

Volumn 324, Issue 1, 2004, Pages 68-78

  Valencia, Jessica V ^a,b   Weldon, Stephen C ^a   Quinn, Douglas ^a   Kiers, Geesje H ^c   DeGroot, Jeroen ^c   TeKoppele, Johan M ^c   Hughes, Thomas E ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c TNO   (Netherlands)

Author keywords

Advanced glycation end products; AGE; Formation kinetics; Glycation; Maillard reaction; RAGE; Receptor for advanced glycation end products; Serum albumin

Indexed keywords

AMINO ACIDS; BINDING ENERGY; CELL MEMBRANES; FRUCTOSE; GLUCOSE; KINETICS; LIGANDS; MAMMALS; REACTION KINETICS;

ADVANCED GLYCATION END PRODUCTS; FORMATION KINETICS; GLYCATION; MAILLARD REACTION; RAGE; SERUM ALBUMIN;

GLYCOSYLATION;

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALDEHYDE DERIVATIVE; BOVINE SERUM ALBUMIN; CARBONYL DERIVATIVE; FRUCTOSE; GLUCOSE; GLYOXYLIC ACID; LIGAND; PENTOSIDINE; RIBOSE;

ARTICLE; BINDING AFFINITY; CHEMICAL REACTION KINETICS; CORRELATION ANALYSIS; FLUORESCENCE; GLYCATION; HUMAN; HUMAN CELL; INCUBATION TIME; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

BOVINAE;

EID: 0344925061     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.09.013     Document Type: Article

References (42)

1. Bierhaus A., Hofmann M.A., Ziegler R., Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc. Res. 37:1998;586-600.
2. Dunn J.A., McCance D.R., Thorpe S.R., Lyons T.J., Baynes J.W. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl) hydroxylysine in human skin collagen. Biochemistry. 30:1991;1205-1210.
3. Reddy S., Bichler J., Wells-Knecht K.J., Thorpe S.R., Baynes J.W. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 34:1995;10872-10878.
4. Verzijl N., DeGroot J., Oldehinkel E., Bank R., Thorpe S.R., Baynes J.W., Bayliss M.T., Bijlsma J.W.J., Lafeber F., TeKoppele J.M. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem. J. 350:2000;381-387.
5. Schleicher E.D., Wagner E., Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:1997;457-468.
6. Miyata T., Ishikawa S., Asahi K., Inagi R., Suzuki D., Horie K., Tatsumi K., Kurokawa K. 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage. FEBS Lett. 445:1999;202-206.
7. Vlassara H., Palace M.R. Diabetes and advanced glycation endproducts. J. Intern. Med. 251(2):2002;87-101.
8. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C.E., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267:1992;14998-15004.
9. Brett J., Schmidt A.M., Yan S.D., Zou S., Weidman E., Pinsky D., Neeper M., Shaw A., Migheli A., Stern D. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143:1993;1699-1712.
10. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:1994;9889-9897.
11. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Yan S., Hofmann M., Yan S.F., Pischetsrieder M., Stern D., Schmidt A.M. N(epsilon)-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274:1999;31740-31749.
12. Hui Y.Y., McAmis W.C., Baynes J.W., Schaeffer R.C. Jr., Wolf M.B. Effect of advanced glycation end products on oxidative stress in endothelial cells in culture: a warning on the use of cells studied in serum-free media. Diabetologia. 44:2001;1310-1317.
13. Khalifah R.G., Todd P., Booth A.A., Yang S.X., Mott J.D., Hudson B.G. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies. Biochemistry. 35(15):1996;4645-4654.
14. Booth A.A., Khalifah R.G., Todd P., Hudson B.G. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J. Biol. Chem. 272(9):1997;5430-5437.
15. Morohoshi M., Fujisawa K., Uchimura I., Numano F. The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann. N. Y. Acad. Sci. 748:1995;562-570.
16. Khechai F., Ollivier V., Bridey F., Amar M., Hakim J., de Prost D. Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler. Thromb. Vasc. Biol. 17(11):1997;2885-2890.
17. McDonald D.R., Bamberger M.E., Combs C.K., Landreth G.E. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18(12):1998;4451-4460.
18. Ichikawa K., Yoshinari M., Iwase M., Wakisaka M., Doi Y., Iino K., Yamamoto M., Fujishima M. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis. 136:1998;281-287.
19. Rojas A., Romay S., Gonzalez D., Herrera B., Delgado R., Otero K. Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. Circ. Res. 86:2000;e50-e54.
20. Gasic-Milenkovic J., Loske C., Deuther-Conrad W., Munch G. Protein "AGEing" - cytotoxicity of a glycated protein increases with its degree of AGE-modification. Z. Gerontol. Geriatr. 34:2001;457-460.
21. Westwood M.E., Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J. Protein Chem. 14(5):1995;359-372.
22. Monnier V.M., Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc. Natl. Acad. Sci. USA. 81:1984;583-587.
23. Uchida K., Kanematsu M., Sakai K., Matsuda T., Hattori N., Mizuno Y., Suzuki D., Miyata T., Notguchi N., Niki E., Osawa T. Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA. 95:1998;4882-4887.
24. Bank R.A., Jansen E.J., Beekman B., TeKoppele J.M. Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate. Anal. Biochem. 240:1996;167-176.
25. Bunn H.F., Higgins P.J. Reaction of monosaccharides with proteins: possible evolutionary significance. Science. 213:1981;222-224.
26. Means G.E., Chang M.K. Nonenzymatic glycosylation of proteins - structure and function changes. Diabetes. 31(Suppl. 3):1982;1-4.
27. Ikeda K., Higashi T., Sano H., Jinnouchi Y., Yoshida M., Araki T., Ueda S., Horiuchi S. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry. 35:1996;8075-8083.
28. Grandhee S.K., Monnier V.M. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J. Biol. Chem. 266(18):1991;11649-11653.
29. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell. Mol. Biol. 44(7):1998;1013-1023.
30. Chappy O., Dosquet C., Wautier M.P., Wautier J.L. Advanced glycation end products, oxidant stress and vascular lesions. Eur. J. Clin. Invest. 27:1997;97-108.
31. Schmidt A.M., Stern D. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol. Metab. 11(9):2000;368-375.
32. Khalifah R.G., Baynes J.W., Hudson B.G. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. Biochem. Biophys. Res. Commun. 257:1999;251-258.
33. Schmidt A.M., Yan S.D., Stern D. The dark side of glucose. Nat. Med. 1:1995;1002-1004.
34. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Slattery T., McClary J., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:1999;889-901.
35. Vlassara H., Brownlee M., Monogue K.R., Dinarello C.A., Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science. 240:1988;1546-1548.
36. Miyata T., Hori O., Zhang J., Yan S.D., Ferran L., Iida Y., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Invest. 98:1996;1088-1094.
37. Schmidt A.M., Hasu M., Popov D., Zhang J.H., Chen J., Yan S.D., Brett J., Cao R., Costache G., Stern D. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc. Natl. Acad. Sci. USA. 91(19):1994;8807-8811.
38. Hori O., Brett J., Slattery T., Cao R., Nitecki D., Morser J., Stern D., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270:1995;25752-25761.
39. Radoff S., Makita Z., Vlassara H. Radioreceptor assay for advanced glycosylation end products. Diabetes. 40(12):1991;1731-1738.
40. Acton S., Resnick D., Freeman M., Ekkel Y., Ashkenas J., Kriegar M. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J. Biol. Chem. 268(5):1993;3530-3537.
41. Wautier J.L., Guillausseau P.J. Diabetes, advanced glycation endproducts and vascular disease. Vasc. Med. 3(2):1998;131-137.
42. Schwenger V., Zeier M., Henle T., Ritz E. Advanced glycation endproducts (AGEs) as uremic toxins. Nahrung. 45(3):2001;172-176.